| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-05-26 | Aveo Oncology (USA - MA) | opening of new premises |
Cancer - Oncology | Opening of new premises | ||
| 2015-05-26 | Sanofi (France) | nomination |
Nomination | |||
| 2015-05-26 | Neurovive Pharmaceutical (Sweden) Sanofi (France) | CicloMulsion® (Cremophor®-free intravenous cyclosporine formulation) | reperfusion injury in cardiovascular disease | development collaboration commercialisation |
Cardiovascular diseases | Collaboration agreement |
| 2015-05-22 | Amgen (USA) AstraZeneca (UK) | five monoclonal antibodies (AMG 139, AMG 157, AMG 181, AMG 557, brodalumab - AMG 827) | asthma, psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, ystemic lupus erythematosus | R&D |
Allergic diseases - Autoimmune diseases - Dermatological diseases - Digestive diseases - Inflammatory diseases - Rheumatic diseases | Termination of an agreement |
| 2015-05-21 | OncoTherapy Science (Japan) Shionogi (Japan) | S-588410 | esophageal cancer | clinical research |
Cancer - Oncology | Milestone |
| 2015-05-21 | Visterra (USA - MA) Agency for Science, Technology and Research (A*STAR) (Singapore) | VIS513 | dengue fever | collaboration development |
Infectious diseases | Collaboration agreement |
| 2015-05-21 | Nabriva Therapeutics (Austria) | nomination |
Infectious diseases | Nomination | ||
| 2015-05-21 | Osiris Therapeutics (USA - MD) | establishment of a new subsidiary |
Regenerative Medicine | Establishment of a new subsidiary in the EU | ||
| 2015-05-20 | Theradiag (France) Hospira (USA - IL) | LISA-TRACKER’s infliximab monitoring kit | rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriasis, psoriatic arthritis | collaboration | Autoimmune diseases - Dermatological diseases - Inflammatory diseases - Digestive diseases - Rheumatic diseases | Collaboration agreement |
| 2015-05-20 | Biomay (Austria) VTU Technology (Austria) | Pichia pastoris expression strains for the commercial production of recombinant allergens | allergic diseases | licensing |
Technology - Services - Allergic diseases | Licensing agreement |
| 2015-05-20 | Amag Pharmaceuticals (USA - MA) NurseWise® (USA) | My Adherence Program™ | collaboration |
Women health | Collaboration agreement | |
| 2015-05-20 | Janssen Biotech, a J&J company (USA - NJ) Novo Nordisk (Denmark) | NKG2D receptor modulators | autoimmune diseases | licensing |
Autoimmune diseases | Licensing agreement |
| 2015-05-20 | Adaptimmune (UK) | nomination |
Cancer - Oncology | Nomination | ||
| 2015-05-20 | CMC Biologics (Denmark - USA) | expansion of a production plant |
Technology - Services | Construction of a production plant | ||
| 2015-05-20 | Faron Pharmaceuticals (Finland) China Medical Systems Holding Limited (China) A&B Ltd (China) | Traumakine® - FP-1201 (human recombinant interferon-beta 1a) | acute respiratory distress syndrome (ARDS) | development commercialisation |
Lung diseases - Respiratory diseases | Development agreement |
| 2015-05-19 | Diaxonhit (France) Felicitex Therapeutics (USA - MA) | novel small molecule anti-cancer compounds active and selective against DYRK | licensing |
Cancer - Oncology | Licensing agreement | |
| 2015-05-19 | Poxel (France) | nomination |
Metabolic diseases | Nomination | ||
| 2015-05-19 | GW Pharmaceuticals (UK) | nomination |
CNS diseases - Neurological diseases - Neurodegenerative diseases | Nomination | ||
| 2015-05-19 | Takeda Pharmaceutical (Japan) The Chemo-Sero-Therapeutic Research Institute (Kaketsuken) (Japan) | Influenza HA Vaccine KAKETSUKEN | seasonal influenza | distribution |
Infectious diseases | Distribution agreement |
| 2015-05-19 | Emergent BioSolutions (USA - MD) ProMetic Life Sciences (Canada) | manufacturing production |
Technology - Services | Production agreement |
